BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25351555)

  • 1. Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study.
    Take S; Mizuno M; Ishiki K; Hamada F; Yoshida T; Yokota K; Okada H; Yamamoto K
    J Gastroenterol; 2015 Jun; 50(6):638-44. PubMed ID: 25351555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K
    J Gastroenterol; 2007 Jan; 42 Suppl 17():21-7. PubMed ID: 17238021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
    Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
    Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Yamamoto K
    J Gastroenterol Hepatol; 2009 Jan; 24(1):107-13. PubMed ID: 18823429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?
    Mabe K; Takahashi M; Oizumi H; Tsukuma H; Shibata A; Fukase K; Matsuda T; Takeda H; Kawata S
    World J Gastroenterol; 2009 Sep; 15(34):4290-7. PubMed ID: 19750572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Shiratori Y
    Am J Gastroenterol; 2005 May; 100(5):1037-42. PubMed ID: 15842576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
    Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding.
    Gisbert JP; Calvet X; Cosme A; Almela P; Feu F; Bory F; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Benages A; Cañete N; Montoro M; Borda F; Pérez-Aisa A; Piqué JM;
    Am J Gastroenterol; 2012 Aug; 107(8):1197-204. PubMed ID: 22613904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
    Gisbert JP; Calvet X; Feu F; Bory F; Cosme A; Almela P; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Cañete N; Benages A; Montoro M; Borda F; Pérez-Aisa A; Piqué JM
    Helicobacter; 2007 Aug; 12(4):279-86. PubMed ID: 17669099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
    JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation.
    Roderick P; Davies R; Raftery J; Crabbe D; Pearce R; Patel P; Bhandari P
    J Med Screen; 2003; 10(3):148-56. PubMed ID: 14561268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
    Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
    Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Helicobacter pylori eradication therapy does not prevent gastric cancer development in all patients].
    Take S; Ishiki K; Mizuno M
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):353-7. PubMed ID: 21403436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.
    Mori G; Nakajima T; Asada K; Shimazu T; Yamamichi N; Maekita T; Yokoi C; Fujishiro M; Gotoda T; Ichinose M; Ushijima T; Oda I
    Gastric Cancer; 2016 Jul; 19(3):911-8. PubMed ID: 26420267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
    Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.